Sun Pharma reveals new clinical data at the 2024 EADV Congress, showing significant improvements in severe skin conditions
Sun Pharmaceutical Industries Limited has made a significant breakthrough in the treatment of severe dermatological conditions, unveiling new clinical efficacy and safety data at the 2024 European Academy of Dermatology and Venereology (EADV) Congress. The latest results, presented in Amsterdam, Netherlands, highlight the promising effects of their flagship treatment for alopecia areata, LEQSELVI (deuruxolitinib), which […]